Thursday, April 23, 2026
28.8 C
Bengaluru

Great Opportunity for Pharma People to Listen to What Doctors have to Say

An insightful and informative Q&A session with Dr. Tejal Lathia, on the challenges of medical practice in Covid19 times…

Telemedicine has become an important tool for doctors to connect with patients.

Digital therapeutics will play an important role in managing chronic conditions.

Specialists are well informed in terms of new and emerging developments in a specialty like endocrinology, it is physicians and doctors in smaller towns that need regular updation.

Patients are better informed now – no point in discouraging them – let them Google, doctors must understand their concerns and point them to reliable sources of health related information.

Instead of insisting that Medical Reps meet doctors during #covid19​, pharma companies can help with concierge services in the management of people with diabetes…

Brand reminders do not serve any useful purpose, they only impair the relationship with doctors…

Now on MedicinMan YouTube Channel https://youtu.be/wqCK574qb-g

Brought to you by Digital Excellence Pharma Academy – A joint initiative of CredoWeb and MedicinMan

You can register on www.credoweb.in and watch over 50+ webinars and Q&A sessions with pharma leaders from India and overseas.

https://www.credoweb.in/discussion/500/selling-in-the-new-normal-the-rise-of-med-rep-20

Hot this week

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img